EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Surveillance for Emerging and Reemerging Pathogens Using Pathogen Agnostic Metagenomic Sequencing in the United States: A Critical Role for Federal Government Agencies

Diane L Downie, Preetika Rao, Corinne David-Ferdon, Sean Courtney, Justin S Lee, Claire Quiner, Pia D M MacDonald, Keegan Barnes, Shelby Fisher, Joanne L Andreadis, Jasmine Chaitram, Matthew R Mauldin und 3 weitere

Health Security · 01.04.2024 · 22 (2) · 85-92

DOI: 10.1089/hs.2023.0099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Security, online erschienen am 16.04.2024. Verfasst von Diane L Downie und 14 weiteren Autor:innen. Beteiligte Einrichtung: Diane L. Downie, PhD, MPH, is Deputy Associate Director for Science, Office of Readiness and Response, US Centers for Disease Control and Prevention,…. Hauptthemen laut MEDLINE: Communicable Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The surveillance and identification of emerging, reemerging, and unknown infectious disease pathogens is essential to national public health preparedness and relies on fluidity, coordination, and interconnectivity between public and private pathogen surveillance systems and networks. Developing a national sentinel surveillance network with existing resources and infrastructure could increase efficiency, accelerate the identification of emerging public health threats, and support coordinated intervention strategies that reduce morbidity and mortality. However, implementing and sustaining programs to detect emerging and reemerging pathogens in humans using advanced molecular methods, such as metagenomic sequencing, requires making large investments in testing equipment and developing networks of clinicians, laboratory scientists, and bioinformaticians. In this study, we sought to gain an understanding of how federal government agencies currently support such pathogen agnostic testing of human specimens in the United States. We conducted a landscape analysis of federal agency websites for publicly accessible information on the availability and type of pathogen agnostic testing and details on flow of clinical specimens and data. The website analysis was supplemented by an expert review of results with representatives from the federal agencies. Operating divisions within the US Department of Health and Human Services and the US Department of Veterans Affairs have developed and sustained extensive clinical and research networks to obtain patient specimens and perform metagenomic sequencing. Metagenomic facilities supported by US agencies were not equally geographically distributed across the United States. Although many entities have work dedicated to metagenomics and/or support emerging infectious disease surveillance specimen collection, there was minimal formal collaboration across agencies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Communicable DiseasesHumansUnited StatesGovernment AgenciesFederal GovernmentPublic Health

Stichwörter der Autor:innen

Disease SurveillanceEmerging pathogensInfectious diseasesMetagenomic SequencingPathogen agnosticPublic health preparedness/response

Autor:innen und Institutionen

  • Diane L. Downie, PhD, MPH, is Deputy Associate Director for Science, Office of Readiness and Response, US Centers for Disease Control and Prevention, Atlanta, GA.
  • Preetika Rao, MPH, is a Health Scientist, US Centers for Disease Control and Prevention, Atlanta, GA.
  • Corinne David-Ferdon, PhD, is Associate Director of Science, Office of Public Health Data, Surveillance, and Technology, US Centers for Disease Control and Prevention, Atlanta, GA.
  • Sean Courtney, PhD, is a Health Scientist, US Centers for Disease Control and Prevention, Atlanta, GA.
  • Justin S. Lee, DVM, PhD, is a Health Scientist, Division of Global Health Protection, US Centers for Disease Control and Prevention, Atlanta, GA.
  • Claire Quiner, MPH, MCP, is a Research Public Health Analyst, Social, Statistical, and Environmental Sciences, RTI International, Research Triangle Park, NC.

Zitieren

APA

Downie, D. L., Rao, P., David-Ferdon, C., Courtney, S., Lee, J. S., Quiner, C., MacDonald, P. D. M., Barnes, K., Fisher, S., Andreadis, J. L., Chaitram, J., Mauldin, M. R., Salerno, R. M., Schiffer, J., & Gundlapalli, A. V. (2024). Surveillance for Emerging and Reemerging Pathogens Using Pathogen Agnostic Metagenomic Sequencing in the United States: A Critical Role for Federal Government Agencies. Health Security, 22(2), 85-92. https://doi.org/10.1089/hs.2023.0099

Vancouver

Downie DL, Rao P, David-Ferdon C, Courtney S, Lee JS, Quiner C, et al. Surveillance for Emerging and Reemerging Pathogens Using Pathogen Agnostic Metagenomic Sequencing in the United States: A Critical Role for Federal Government Agencies. Health Security. 2024;22(2):85-92. doi:10.1089/hs.2023.0099

BibTeX
@article{Downie2024,
  author = {Downie, Diane L and Rao, Preetika and David-Ferdon, Corinne and Courtney, Sean and Lee, Justin S and Quiner, Claire and MacDonald, Pia D M and Barnes, Keegan and Fisher, Shelby and Andreadis, Joanne L and Chaitram, Jasmine and Mauldin, Matthew R and Salerno, Reynolds M and Schiffer, Jarad and Gundlapalli, Adi V},
  title = {Surveillance for Emerging and Reemerging Pathogens Using Pathogen Agnostic Metagenomic Sequencing in the United States: A Critical Role for Federal Government Agencies},
  journal = {Health Security},
  year = {2024},
  volume = {22},
  number = {2},
  pages = {85--92},
  doi = {10.1089/hs.2023.0099}
}
Kostenlos starten →